Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The concern for equity in health

S Anand1

  • 1St Catherine's College, Oxford OX1 3UJ, UK. sudhir.anand@economics.ox.ac.uk

Journal of Epidemiology and Community Health
|June 25, 2002
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complementary cross-gated fusion framework for brain tumor segmentation using MR images (CoGFu Net).

Journal of neuroscience methods·2026
Same author

Therapeutic Outcomes of Aloe vera Gel Compared with Triamcinolone Acetonide in Minor Aphthous Stomatitis.

Nigerian journal of clinical practice·2026
Same author

Modelling aerosol evolution under quiescent and turbulent conditions using a coupled fluid-particle dynamics solver incorporating fractal morphology.

Scientific reports·2026
Same author

Complete tumor regression with exclusive Ayurvedic treatment in adenocarcinoma of prostate: a case report.

Journal of medical case reports·2026
Same author

Trastuzumab deruxtecan in hormone receptor-positive, HER2-low/-ultralow metastatic breast cancer (DESTINY-Breast06): outcome analyses by time to progression on prior first-line endocrine therapy with CDK4/6 inhibitor and baseline burden of disease.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC.

ESMO open·2026